secwatch / observer
8-K filed November 8, 2022, 6:59 PM ET ticker CLVT CIK 0001764046
earnings confidence high sentiment negative materiality 0.75

Clarivate Q3 revenue $635.7M (+43.8% YoY), net loss $4.4B on goodwill impairment; lowers 2022 outlook

CLARIVATE PLC

2022-FY EPS reported -$6.66 revenue$1,984,500,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CLARIVATE PLC reported third quarter ended September 30, 2022 results: revenue $635.7 million.

Period
third quarter ended September 30, 2022
Revenue
$635.7 million
Result
reported results
Exact text from the filing
and insights to accelerate the pace of innovation, today reported results for the third quarter ended September 30, 2022. Third Quarter 2022 Financial Highlights • Revenues of $635.7 million increased 43.8%, and 50.9% at constant currency driven primarily by the acquisition of ProQuest • Organic revenues (1) increased 1.2% as increases in subscription revenues of
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CLARIVATE PLC reported nine months ended September 30, 2022 results: revenue $1,984.5 million.

Period
nine months ended September 30, 2022
Revenue
$1,984.5 million
Result
reported results
Exact text from the filing
and cost savings from integration programs; Adjusted EBITDA Margin (1) of 42.7% decreased 30 basis points Nine Months Ended September 30, 2022 Financial Highlights • Revenues of $1,984.5 million increased 50.8%, and 56.1% at constant currency driven primarily by the acquisition of ProQuest • Organic revenues (1) increased 3.4% as increases in subscription revenues of
View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

CLARIVATE PLC filing history →

Source: SEC EDGAR
accession 0001764046-22-000166
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.